EyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPS0pNQnFBWENtcFppVm1lNnZ1RnVRV3pYT2luc2RnMk9QYVFrb1g5VkVQNXlDbXdRMnR2Yk54Ym9mX0xiSnJPbDI1T29GNTVNeGFuUFFzZDZ4OXQxcGo2QlVkRU1velpHUTQ4WGdrcGdaTHlmMkUxVWlQMVBkWFNmVFdBMzBzaGYwZlQ0MFF5ak1qWC1IOGxtN2RQdGhhVkFBWFJfbDZZMEFIbF9FRVVjSG83NWdsTzFmVF9wMGtySTFCQQ?oc=5" target="_blank">EyePoint's drug for age-related eye disease fails late-stage trial, shares tank</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Boots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMReport highlights flaws in ADHD and autism care
There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found.
October 9, 2026 at 01:52 PMHumana surges after topping 2027 Medicare star ratings - Reuters
Humana surges after topping 2027 Medicare star ratings Reuters
October 9, 2026 at 01:33 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMUS, European telecom stocks slide as SpaceX spectrum deal rattles sector - Reuters
US, European telecom stocks slide as SpaceX spectrum deal rattles sector Reuters
October 9, 2026 at 11:46 AMIT leads rebound in Indian shares; TCS jumps on quarterly results - Reuters
IT leads rebound in Indian shares; TCS jumps on quarterly results Reuters
October 9, 2026 at 02:16 AM